NCT00553241Unknown不适用
Phase 1 of Clinical Trial of Risk Factor, Prognosis, Imaging and Standard Management of Transient Ischemic Attack.
Capital Medical University1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2007年6月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 1
- 试验地点
- 1
- 主要终点
- end points are defined as follow: transient ischemic attack, stroke, angina, myocardial infraction, peripheral vascular disease, intracerebral hemorrhage and other vascular death.
研究概览
简要总结
The purpose of this study is to determine whether the ABCD2 score can be used in patients with transient ischemic attack, admitted to Beijing anzhen hospital, to evaluate the prognosis, risk factor of those patients.
详细描述
The feasibility of risk stratification of patients with acute transient ischemic attack admitted to Beijing anzhen hospital by the ABCD2 score system is yet to be determined. The aim of this paper was to evaluate and validate the short-term prognosis of TIA patients in Peking area using this new score system.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Every patient admitted to Beijing anzhen hospital with transient ischemic attack will be enrolled in this study, from 06/2007 to 12/
- •duration of the symptom not larger than 1 hour.
- •Magnetic resonance imaging negative on DWI(no fresh infarction).
- •Old infarction or not the criminal infarction.
排除标准
- •Patients with hemorrhage stroke were excluded.
结局指标
主要结局
end points are defined as follow: transient ischemic attack, stroke, angina, myocardial infraction, peripheral vascular disease, intracerebral hemorrhage and other vascular death.
时间窗: two year
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
1 期
ALS20-101 Lentiviral Gene Therapy for Beta ThalassemiaBeta-ThalassemiaNCT06364774Children's Hospital of Philadelphia12
已完成
1 期
Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular CarcinomaAdvanced Hepatocellular CarcinomaNCT00534664University of Sao Paulo40
已完成
1 期
Safety, Tolerability and Pharmacokinetics Study of STP1 in a Subgroup of Patients With Autism Spectrum Disorder (ASD)Autism Spectrum DisorderNCT04644003Stalicla SA12
进行中（未招募）
1 期
Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma PatientsRelapsed or Refractory Hodgkin's LymphomaNCT05300282Fondazione Italiana Linfomi - ETS122
已完成
2 期
Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell CarcinomaCarcinoma, Renal CellNCT00073125Abbott103